Both of these biological events aggravate myocardial hypertrophy and fibrosis, while miR-351 plays a protective role in myocardial hypertrophy by directly acting on MLK3 to inhibit the occurrence of pyroptosis and ferroptosis (Wang et al. 2020). Here, MAP3K11 is linked to cardiac hypertrophy.